Mostrando 101,801 - 101,820 Resultados de 102,251 Para Buscar '"renal"', tiempo de consulta: 0.67s Limitar resultados
  1. 101801
    por González, Jessica, de Batlle, Jordi, Benítez, Iván D., Torres, Gerard, Santisteve, Sally, Targa, Adriano D.S., Gort-Paniello, Clara, Moncusí-Moix, Anna, Aguilà, Maria, Seck, Fatty, Ceccato, Adrián, Ferrer, Ricard, Motos, Anna, Riera, Jordi, Fernández, Laia, Menéndez, Rosario, Lorente, José Ángel, Peñuelas, Oscar, Garcia-Gasulla, Dario, Peñasco, Yhivian, Ricart, Pilar, Abril Palomares, Elena, Aguilera, Luciano, Rodríguez, Alejandro, Boado Varela, Maria Victoria, Beteré, Belén, Pozo-Laderas, Juan Carlos, Solé-Violan, Jordi, Salvador-Adell, Inmaculada, Novo, Mariana Andrea, Barberán, José, Amaya Villar, Rosario, Garnacho-Montero, José, Gómez, José M., Blandino Ortiz, Aaron, Tamayo Lomas, Luis, Úbeda, Alejandro, Catalán-González, Mercedes, Sánchez-Miralles, Angel, Martínez Varela, Ignacio, Jorge García, Ruth Noemí, Franco, Nieves, Gumucio-Sanguino, Víctor D., Bustamante-Munguira, Elena, Valdivia, Luis Jorge, Caballero, Jesús, Gallego, Elena, Rodríguez, Covadonga, Castellanos-Ortega, Álvaro, Trenado, Josep, Marin-Corral, Judith, Albaiceta, Guillermo M., de la Torre, Maria del Carmen, Loza-Vázquez, Ana, Vidal, Pablo, Añón, Jose M., Carbajales Pérez, Cristina, Sagredo, Victor, Carbonell, Nieves, Socias, Lorenzo, Barberà, Carme, Estella, Angel, Diaz, Emili, de Gonzalo-Calvo, David, Torres, Antoni, Barbé, Ferran
    Publicado 2023
    “…CONCLUSION: Age and CLD, reflecting patients’ baseline vulnerability, and markers of COVID-19 severity, such as duration of IMV and renal failure, were key factors associated with impaired D(LCO) and CT abnormalities.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 101802
    “…Les antécédents les plus fréquents étaient l’hypertension artérielle (71,4 %), diabète (21,8 %) et insuffisance rénal (7,1 %). La pathologie néoplasique prédominante était le cancer pulmonaire (n = 5), suivi par le cancer du sein (n = 3), cancer du colon (n = 2), cancer cavum (n = 1), colon (n = 1), estomac (n = 1) et cancer du prostate (n = 1). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 101803
  4. 101804
  5. 101805
    “…Moreover, the effect of AGE-Tf on human renal tubular epithelial cells (HK-2) was investigated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 101806
    “…Lors des analyses stratifiées par type de cancer, on observait un risque significativement plus élevé de diagnostic de cancer rénal (aHR 3,16, IC 95% 2,33-4,27), de cancers hématologiques (aHR 2,54, IC 95% 2,07-3,12), de cancer du côlon (aHR 1,72, IC 95% 1,34-2,21) et de cancer pulmonaire (aHR 1,70, IC 95% 1,39-2,08). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 101807
    “…Other common side effects of amphotericin B are renal toxicities, hepatic toxicities and electrolyte imbalances, mainly Hypokalemia and Hypomagnesemia. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 101808
    por Reber, Josefine Astrid
    Publicado 2015
    “…To improve this situation, we aimed to develop and evaluate strategies for the performance of FR-targeted radionuclide therapy by decreasing the renal uptake of radiofolates and thereby reducing potential nephrotoxic effects. …”
    Enlace del recurso
  9. 101809
  10. 101810
  11. 101811
    “…RESULTS: Patient demographics, comorbidities, baseline laboratory, vital parameters, source of infection, baseline lactate levels, and lactate clearance at 3 h and 6 h, Sequential Organ Failure scores, need for invasive mechanical ventilation, days on mechanical ventilation, and renal replacement therapy-free days within 28 d, duration of intensive care unit stay, and hospital stay were comparable between the two groups. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 101812
    “…BACKGROUND: Axitinib is approved by the FDA for the treatment of advanced renal cell carcinoma (RCC) after failure of 1 previous systemic therapy and is distributed primarily through specialty pharmacies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 101813
    “…BACKGROUND: Diabetes and hypertension are the 2 major causes of endstage renal disease. The rate of chronic kidney disease (CKD) secondary to diabetes and/or hypertension is on the rise, and the related health care costs represent a significant economic burden. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 101814
    “…METHODS: Search methods: We searched the Cochrane Renal Group's Specialised Register to 5 June 2012 through contact with the Trials' Search Co-ordinator using search terms relevant to this review. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 101815
    “…METHODS: Search methods: We searched the Cochrane Renal Group's Specialised Register to 5 June 2012 through contact with the Trials' Search Co-ordinator using search terms relevant to this review. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 101816
    “…Introduction: Sodium-Glucose Cotransporter Inhibitors (SGLT2i) treatment is increasing partly due to its cardiovascular and renal benefits, enlarging the population at-risk for euglycemic diabetic ketoacidosis (euDKA), a potentially life-threatening adverse event associated with SGLT2i use. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 101817
    “…Serum T1Ab levels and fasting plasma glucose, HbA1c, c-peptide, Ca (tolerated ≤11.5 mg/dl), P, ALP, Ca/Cr 2-hr urine morning sample, 25(OH)D, 1-25(OH)2D with renal ultrasound in cases with hypercalcemia/hypercalciuria (tolerated ≤50%, or at the upper normal for age) were determined before and q3-6 months after initiation of calcitriol (0.05 mcg/Kg/day) 0.25-0.5 x 1-3/day or its synthetic analogue, paricalcitol (thrice the calcitriol dose) 1-4 mcg x 1-3/day p.o. under cholecalciferol repletion. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 101818
    “…Background: Conventional therapy with oral calcium (Ca) and active vitamin D (vitD) supplementation for chronic hypoparathyroidism (cHP) can induce or aggravate hypercalciuria and may lead to detrimental long-term renal complications. AZP-3601 is a novel 36-amino-acid peptide designed to activate the R(0) conformation of the PTH 1 receptor which produces a prolonged calcemic response despite a short half-life. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 101819
    Publicado 2023
    “…In this study, we analyzed the relationship between serum VitD metabolites and renal impairment in patients with diabetic kidney disease (DKD). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 101820
    “…RESULTS: The results of pan-cancer analysis and differential analysis collectively showed that except for renal clear cell carcinoma, the expression of lncRNA miR143HG in other cancer tissues was higher than that in healthy tissues, and the differences were significant in LUSC. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS